Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. (WSE:VOX) for PLN 11 million on September 21, 2012. Enterprise Investors already made an upfront payment of PLN 5 million, with the remainder payable at a later date, subject to certain conditions. Enterprise Investors will finance the development of the radiotherapy center in cooperation with a private company and a medical university.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
94.6 PLN | +1.28% | +5.11% | +20.36% |
May. 27 | Voxel S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Mar. 11 | Amadeus IT Group Buys Voxel Media in EUR113 Million Deal | MT |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.36% | 245M | |
+68.94% | 4.34B | |
+0.35% | 2.69B | |
+3.72% | 2.66B | |
-55.09% | 1.8B | |
-18.60% | 1.68B | |
-21.23% | 1.42B | |
+15.60% | 1.19B | |
-49.14% | 1.03B | |
+14.37% | 949M |
- Stock Market
- Equities
- VOX Stock
- News Voxel S.A.
- Polish Enterprise Fund VII, fund of Enterprise Investors reached an agreement to acquire Center for Cancer Diagnostics and Therapy from Voxel S.A. for PLN 11 million.